{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:53:45Z","timestamp":1793836425517,"version":"4.6.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"PUTI Grant","award":["NKB-648\/UN2.RST\/HKP.05.00\/2023"],"award-info":[{"award-number":["NKB-648\/UN2.RST\/HKP.05.00\/2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting 5\u201320% of reproductive-age women. However, the treatment of PCOS is mainly based on symptoms and not on its pathophysiology. Neuroendocrine disturbance, as shown by an elevated LH\/FSH ratio in PCOS patients, was thought to be the central mechanism of the syndrome, especially in lean PCOS. LH and FSH secretion are influenced by GnRH pulsatility of GnRH neurons in the hypothalamus. Kisspeptin is the main regulator of GnRH secretion, whereas neurokinin B (NKB) and dynorphin regulate kisspeptin secretion in KNDy neurons. This study aims to deepen the understanding of the neuroendocrine disorder in lean PCOS patients and its potential pathophysiology-based therapy. A cross-sectional study was performed at Dr. Cipto Mangunkusumo Kencana Hospital and the IMERI UI HRIFP cluster with 110 lean PCOS patients as subjects. LH, FSH, LH\/FSH ratio, kisspeptin, NKB, dynorphin, leptin, adiponectin, AMH, fasting blood glucose, fasting insulin, HOMA-IR, testosterone, and SHBG were measured. Bivariate and path analyses were performed to determine the relationship between variables. There was a negative association between dynorphin and kisspeptin, while NKB levels were not associated with kisspeptin. There was no direct association between kisspeptin and the LH\/FSH ratio; interestingly, dynorphin was positively associated with the LH\/FSH ratio in both bivariate and pathway analyses. AMH was positively correlated with the LH\/FSH ratio in both analyses. Path analysis showed an association between dynorphin and kisspeptin levels in lean PCOS, while NKB was not correlated with kisspeptin. Furthermore, there was a correlation between AMH and the LH\/FSH ratio, but kisspeptin levels did not show a direct significant relationship with the LH\/FSH ratio. HOMA-IR was negatively associated with adiponectin levels and positively associated with leptin and FAI levels. In conclusion, AMH positively correlates with FAI levels and is directly associated with the LH\/FSH ratio, showing its important role in neuroendocrinology in lean PCOS. From the path analysis, AMH was also an intermediary variable between HOMA-IR and FAI with the LH\/FSH ratio. Interestingly, this study found a direct positive correlation between dynorphin and the LH\/FSH ratio, while no association between kisspeptin and the LH\/FSH ratio was found. Further research is needed to investigate AMH and dynorphin as potential therapeutic targets in the management of lean PCOS patients.<\/jats:p>","DOI":"10.1038\/s41598-024-58064-0","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T11:01:45Z","timestamp":1712574105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Gita","family":"Pratama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budi","family":"Wiweko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Asmarinah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indah S.","family":"Widyahening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinovita","family":"Andraini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartanto","family":"Bayuaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andon","family":"Hestiantoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"58064_CR1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.22270\/jddt.v9i3.2661","volume":"9","author":"M Mohd","year":"2019","unstructured":"Mohd, M., Maqbool, M., Dar, M. A. & Mushtaq, I. Polycystic ovary syndrome, a modern epidemic: An overview. J. Drug Deliv. Ther. 9, 641\u2013644 (2019).","journal-title":"J. Drug Deliv. Ther."},{"key":"58064_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19\u201325 (2004).","journal-title":"Fertil. Steril."},{"key":"58064_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber, T. M. & Franks, S. Obesity and polycystic ovary syndrome. Clin. Endocrinol. (Oxf). 95, 531\u2013541. https:\/\/doi.org\/10.1111\/cen.14421 (2021).","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"58064_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1179558119874042","volume":"9","author":"TM Barber","year":"2019","unstructured":"Barber, T. M., Hanson, P., Weickert, M. O. & Franks, S. Obesity and polycystic ovary syndrome: Implications for pathogenesis and novel management strategies. Clin. Med. Insights Reprod. Health. 9, 13. https:\/\/doi.org\/10.1177\/1179558119874042 (2019).","journal-title":"Clin. Med. Insights Reprod. Health."},{"issue":"2","key":"58064_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4274\/tjem.2761","volume":"19","author":"E Bozkirli","year":"2015","unstructured":"Bozkirli, E. et al. Insulin resistance in non-obese polycystic ovary syndrome subjects and relation with family history of diabetes mellitus. Turk. J. Endocrinol. Metab. 19(2), 55\u201359. https:\/\/doi.org\/10.4274\/tjem.2761 (2015).","journal-title":"Turk. J. Endocrinol. Metab."},{"key":"58064_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0974-1208.170394","volume":"8","author":"S Sharma","year":"2015","unstructured":"Sharma, S. & Majumdar, A. Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women. J. Hum. Reprod. Sci. 8, 202\u2013208 (2015).","journal-title":"J. Hum. Reprod. Sci."},{"key":"58064_CR7","first-page":"1","volume":"2014","author":"J Rojas","year":"2014","unstructured":"Rojas, J. et al. Polycystic ovary syndrome, insulin resistance, and obesity: Navigating the pathophysiologic labyrinth. Int. J. Reprod. Med. 2014, 1\u201317 (2014).","journal-title":"Int. J. Reprod. Med."},{"issue":"3","key":"58064_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1210\/jc.2014-2569","volume":"100","author":"C Moran","year":"2015","unstructured":"Moran, C., Arriaga, M., Arechavaleta-Velasco, F. & Moran, S. Adrenal androgen excess and body mass index in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 100(3), 942\u2013950. https:\/\/doi.org\/10.1210\/jc.2014-2569 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"58064_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/620605","author":"L Tock","year":"2014","unstructured":"Tock, L., Carneiro, G., Pereira, A. Z., Tufik, S. & Zanella, M. T. Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome. Int. J. Endocrinol. https:\/\/doi.org\/10.1155\/2014\/620605 (2014).","journal-title":"Int. J. Endocrinol."},{"issue":"12","key":"58064_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/TACG.S200341","volume":"24","author":"MJ Khan","year":"2019","unstructured":"Khan, M. J., Ullah, A. & Basit, S. Genetic basis of polycystic ovary syndrome (PCOS): Current perspectives. Appl. Clin. Genet. 24(12), 249\u2013260. https:\/\/doi.org\/10.2147\/TACG.S200341 (2019).","journal-title":"Appl. Clin. Genet."},{"issue":"14","key":"58064_CR11","doi-asserted-by":"publisher","first-page":"1326546","DOI":"10.3389\/fendo.2023.1326546","volume":"9","author":"L Zheng","year":"2024","unstructured":"Zheng, L. et al. Obesity and its impact on female reproductive health: Unraveling the connections. Front. Endocrinol. (Lausanne). 9(14), 1326546. https:\/\/doi.org\/10.3389\/fendo.2023.1326546 (2024).","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"16","key":"58064_CR12","doi-asserted-by":"publisher","first-page":"117955142311964","DOI":"10.1177\/11795514231196461","volume":"11","author":"GA Abruzzese","year":"2023","unstructured":"Abruzzese, G. A., Ferreira, S. R., Ferrer, M. J., Silva, A. F. & Motta, A. B. Prenatal androgen excess induces multigenerational effects on female and male descendants. Clin. Med. Insights Endocrinol. Diabetes 11(16), 11795514231196460. https:\/\/doi.org\/10.1177\/11795514231196461 (2023).","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"issue":"1","key":"58064_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/cells12010174","volume":"12","author":"M Jozkowiak","year":"2022","unstructured":"Jozkowiak, M. et al. Endocrine disrupting chemicals in polycystic ovary syndrome: The relevant role of the theca and granulosa cells in the pathogenesis of the ovarian dysfunction. Cells 12(1), 174. https:\/\/doi.org\/10.3390\/cells12010174 (2022).","journal-title":"Cells"},{"issue":"1","key":"58064_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12291-023-01130-7","volume":"39","author":"KU Nisa","year":"2024","unstructured":"Nisa, K. U. et al. Molecular mechanisms in the etiology of polycystic ovary syndrome (PCOS): A multifaceted hypothesis towards the disease with potential therapeutics. Indian J. Clin. Biochem. 39(1), 18\u201336. https:\/\/doi.org\/10.1007\/s12291-023-01130-7 (2024).","journal-title":"Indian J. Clin. Biochem."},{"key":"58064_CR15","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s43032-023-01262-4","volume":"30","author":"AM Elsayed","year":"2023","unstructured":"Elsayed, A. M. et al. Clinical phenotypes of PCOS: A cross-sectional study. Reprod. Sci. 30, 3261\u20133272. https:\/\/doi.org\/10.1007\/s43032-023-01262-4 (2023).","journal-title":"Reprod. Sci."},{"key":"58064_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2023.114334","author":"C Voigt","year":"2023","unstructured":"Voigt, C., Gahr, M. & Bennett, N. C. Differential regulation of Kiss1 gene expression by oestradiol in the hypothalamus of the female Damaraland mole-rat, an induced ovulator. Gen. Comp. Endocrinol. https:\/\/doi.org\/10.1016\/j.ygcen.2023.114334 (2023).","journal-title":"Gen. Comp. Endocrinol."},{"key":"58064_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2013.00022","volume":"4","author":"I Franceschini","year":"2013","unstructured":"Franceschini, I. & Desroziers, E. Development and aging of the kisspeptin-GPR54 system in the mammalian brain: What are the impacts on female reproductive function?. Front. Endocrinol. 4, 1\u201320. https:\/\/doi.org\/10.3389\/fendo.2013.00022 (2013).","journal-title":"Front. Endocrinol."},{"key":"58064_CR18","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1155\/2020\/5216903","volume":"25","author":"MM Abdalqader","year":"2020","unstructured":"Abdalqader, M. M. & Hussein, S. S. Metastatin as a marker for hyperandrogenemia in Iraqi women with polycystic ovary syndrome. Obstet. Gynecol. Int. 25, 2020. https:\/\/doi.org\/10.1155\/2020\/5216903 (2020).","journal-title":"Obstet. Gynecol. Int."},{"key":"58064_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/09513590.2017.1379499","volume":"34","author":"U Gorkem","year":"2018","unstructured":"Gorkem, U., Togrul, C., Arslan, E. & Oruc, A. S. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome?. Gynecol. Endocrinol. 34, 157\u2013160 (2018).","journal-title":"Gynecol. Endocrinol."},{"key":"58064_CR20","first-page":"1","volume":"720","author":"YE Jeon","year":"2013","unstructured":"Jeon, Y. E. et al. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol. Obstet. Invest. 720, 1\u20137 (2013).","journal-title":"Gynecol. Obstet. Invest."},{"key":"58064_CR21","first-page":"1","volume":"4","author":"B Umayal","year":"2018","unstructured":"Umayal, B. & Wijeyaratne, C. N. Polycystic ovary syndrome: Genetic contributions from the hypothalamic-pituitary-gonadal axis. Int. Arch. Endocrinol. Clin. Res. 4, 1\u20138 (2018).","journal-title":"Int. Arch. Endocrinol. Clin. Res."},{"key":"58064_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2019.1597343","volume":"35","author":"T Wang","year":"2019","unstructured":"Wang, T., Han, S., Tian, W., Zhao, M. & Zhang, H. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Gynecol. Endocrinol. 35, 1\u20134 (2019).","journal-title":"Gynecol. Endocrinol."},{"key":"58064_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejogrb.2014.06.004","volume":"180","author":"SA Yilmaz","year":"2014","unstructured":"Yilmaz, S. A. et al. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 180, 56\u201360. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.06.004 (2014).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"58064_CR24","doi-asserted-by":"publisher","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","volume":"17","author":"M Dapas","year":"2020","unstructured":"Dapas, M. et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. Plos Med. 17(6), e1003132. https:\/\/doi.org\/10.1371\/journal.pmed.1003132 (2020).","journal-title":"Plos Med."},{"issue":"3","key":"58064_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/jhrs.JHRS_77_17","volume":"10","author":"M Goyal","year":"2017","unstructured":"Goyal, M. & Dawood, A. Debates regarding lean patients with polycystic ovary syndrome: A narrative review. J. Hum. Reprod. Sci. 10(3), 154. https:\/\/doi.org\/10.4103\/jhrs.JHRS_77_17 (2017).","journal-title":"J. Hum. Reprod. Sci."},{"key":"58064_CR26","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1172\/JCI139681","volume":"130","author":"A Abbara","year":"2020","unstructured":"Abbara, A. et al. Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders. J. Clin. Invest. 130, 6739\u20136753 (2020).","journal-title":"J. Clin. Invest."},{"key":"58064_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01160-0","author":"A Szeliga","year":"2019","unstructured":"Szeliga, A., Podfigurna, A., Bala, G. & Meczekalski, G. Kisspeptin and neurokinin B analogs use in gynecological endocrinology: Where do we stand?. J. Endocrinol. Invest. https:\/\/doi.org\/10.1007\/s40618-019-01160-0 (2019).","journal-title":"J. Endocrinol. Invest."},{"key":"58064_CR28","first-page":"654","volume-title":"Multivariate Data Analysis","author":"JF Hair","year":"2010","unstructured":"Hair, J. F., Black, W. C., Babin, W. J. & Anderson, R. E. Multivariate Data Analysis 7th edn, 654\u2013655 (Prentice-Hall, 2010).","edition":"7"},{"key":"58064_CR29","doi-asserted-by":"publisher","unstructured":"Karimah, P. & Hestiantoro, A. The cut off of ferriman gallwey score for PCOS in Asia and the degree of hyperandrogenism indicator. In ASPIRE Conferences Proceeding. 186\u201392. (2016).https:\/\/doi.org\/10.18502\/kme.v1i1.640","DOI":"10.18502\/kme.v1i1.640"},{"key":"58064_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14740\/jem716","volume":"11","author":"S Morshed","year":"2021","unstructured":"Morshed, S., Banu, H., Akhtar, N., Sultana, T. & Begum, A. Luteinizing hormone to follicle-stimulating hormone ratio significantly correlates with androgen level and manifestations are more frequent with hyperandrogenemia in women with polycystic ovary syndrome. J. Endocrinol. Metab. 11, 14\u201321 (2021).","journal-title":"J. Endocrinol. Metab."},{"key":"58064_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2017.12.007","author":"NA Malini","year":"2017","unstructured":"Malini, N. A. & George, K. R. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS)-clinical based case control study. Gen. Comp. Endocrinol. https:\/\/doi.org\/10.1016\/j.ygcen.2017.12.007 (2017).","journal-title":"Gen. Comp. Endocrinol."},{"key":"58064_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino, I. et al. Novel role for anti-mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat. Commun. 7, 1\u201312 (2016).","journal-title":"Nat. Commun."},{"key":"58064_CR33","doi-asserted-by":"publisher","first-page":"e47198","DOI":"10.7554\/eLife.47198","volume":"8","author":"SA Malone","year":"2019","unstructured":"Malone, S. A. et al. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism. Elife 8, e47198 (2019).","journal-title":"Elife"},{"issue":"5","key":"58064_CR34","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/ijerph19053089","volume":"19","author":"A Szeliga","year":"2022","unstructured":"Szeliga, A. et al. Neuroendocrine determinants of polycystic ovary syndrome. Int. J. Environ. Res. Public Health. 19(5), 3089. https:\/\/doi.org\/10.3390\/ijerph19053089 (2022).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"58064_CR35","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1210\/en.2018-00435","volume":"159","author":"PW Weems","year":"2018","unstructured":"Weems, P. W. et al. Evidence that dinorfin acts upon KNDy and GnRH neurons during GnRH pulse termination in the ewe. Endocrinology. 159, 3187\u20133199 (2018).","journal-title":"Endocrinology."},{"key":"58064_CR36","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1210\/en.2018-00389","volume":"159","author":"AM Moore","year":"2018","unstructured":"Moore, A. M., Coolen, L. M., Porter, D. T., Goodman, R. L. & Lehman, M. N. KNDy cells revisited. Endocrinology. 159, 3219\u20133234 (2018).","journal-title":"Endocrinology."},{"key":"58064_CR37","first-page":"520","volume-title":"Polycystic Ovary Syndrome and Hyperandrogenic States","author":"RJ Chang","year":"2019","unstructured":"Chang, R. J. & Dumesic, D. A. Yen and Jaffe\u2019s Reproductive Endocrinology. In Polycystic Ovary Syndrome and Hyperandrogenic States 8th edn 520\u2013555 (Elsevier, Munich, 2019).","edition":"8"},{"key":"58064_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.peptides.2014.12.011","volume":"64","author":"A Abachi","year":"2015","unstructured":"Abachi, A. et al. Significance of serum neurokinin b and kisspeptin levels in the differential diagnosis of premature thelarche and idiopathic central precocious puberty. Peptides. 64, 29\u201333 (2015).","journal-title":"Peptides."},{"issue":"5","key":"58064_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield, R. L. & Ehrmann, D. A. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 37(5), 467\u2013520. https:\/\/doi.org\/10.1210\/er.2015-1104 (2016).","journal-title":"Endocr. Rev."},{"key":"58064_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rmb2.12262","volume":"18","author":"S Osuka","year":"2019","unstructured":"Osuka, S. et al. Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod. Med. Biol. 18, 151\u2013160 (2019).","journal-title":"Reprod. Med. Biol."},{"key":"58064_CR41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/humupd\/dmu009","volume":"20","author":"K Skorupskaite","year":"2014","unstructured":"Skorupskaite, K., George, J. T. & Anderson, R. A. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum. Reprod. Update 20, 485\u2013500 (2014).","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"58064_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000336376","volume":"97","author":"J Young","year":"2013","unstructured":"Young, J. et al. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: Physiological, pathophysiological and therapeutic implications. Neuroendocrinology. 97(2), 193\u2013202. https:\/\/doi.org\/10.1159\/000336376 (2013).","journal-title":"Neuroendocrinology."},{"key":"58064_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ijgo.12527","volume":"142","author":"MH Daghestani","year":"2018","unstructured":"Daghestani, M. H. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among nonobese Saudi women. Int. J. Gynaecol. Obstet. 142, 162\u2013169 (2018).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"58064_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12020-018-1609-1","volume":"61","author":"K Katulski","year":"2018","unstructured":"Katulski, K., Pod, A., Czyzyk, A., Meczekalski, B. & Genazzani, A. D. Kisspeptin and LH pulsatile temporal coupling in PCOS patients. Endocrine. 61, 149\u2013157 (2018).","journal-title":"Endocrine."},{"issue":"12","key":"58064_CR45","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/humrep\/dez205","volume":"34","author":"A Romero-Ruiz","year":"2019","unstructured":"Romero-Ruiz, A. et al. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome. Hum. Reprod. 34(12), 2495\u20132512. https:\/\/academic.oup.com\/humrep, https:\/\/doi.org\/10.1093\/humrep\/dez205 (2019).","journal-title":"Hum. Reprod."},{"issue":"2","key":"58064_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/19396368.2014.973123","volume":"61","author":"J Li","year":"2015","unstructured":"Li, J. et al. The relationship between serum anti-M\u00fcllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome. Syst. Biol. Reprod. Med. 61(2), 103\u2013109. https:\/\/doi.org\/10.3109\/19396368.2014.973123 (2015).","journal-title":"Syst. Biol. Reprod. Med."},{"issue":"10","key":"58064_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10815-014-0300-6","volume":"31","author":"B Wiweko","year":"2014","unstructured":"Wiweko, B. et al. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. J. Assist. Reprod. Genet. 31(10), 1311\u20131316. https:\/\/doi.org\/10.1007\/s10815-014-0300-6 (2014).","journal-title":"J. Assist. Reprod. Genet."},{"key":"58064_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3207-y","volume":"11","author":"B Wiweko","year":"2018","unstructured":"Wiweko, B., Indra, I., Susanto, C., Natadisastra, M. & Hestiantoro, A. The correlation between serum AMH and HOMA IR among PCOS phenotypes. BMC Res. Notes. 11, 1\u20136 (2018).","journal-title":"BMC Res. Notes."},{"issue":"12","key":"58064_CR49","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1093\/humrep\/dez214","volume":"34","author":"N Dilaver","year":"2019","unstructured":"Dilaver, N. et al. The regulation and signalling of anti-M\u00fcllerian hormone in human granulosa cells: Relevance to polycystic ovary syndrome. Hum. Reprod. 34(12), 2467\u20132479. https:\/\/doi.org\/10.1093\/humrep\/dez214 (2019).","journal-title":"Hum. Reprod."},{"key":"58064_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-020-03576-x","volume":"78","author":"MSB Silva","year":"2021","unstructured":"Silva, M. S. B. & Giacobini, P. New insights into anti M\u00fcllerian hormone role in the hypothalamic\u2013pituitary\u2013gonadal axis and neuroendocrine development. Cell Mol. Life Sci. 78, 1\u201316 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"58064_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0031-1275519","volume":"29","author":"V Padmanabhan","year":"2013","unstructured":"Padmanabhan, V. & Velga-Lopez, A. Developmental origin of reproductive and metabolic dysfunctions: Androgenic versus estrogenic reprogramming. Semin. Reprod. Med. 29, 173\u2013186 (2013).","journal-title":"Semin. Reprod. Med."},{"issue":"3","key":"58064_CR52","first-page":"313","volume":"17","author":"NA Malini","year":"2021","unstructured":"Malini, N. A. & Roy, G. K. Influence of insulin on LH, testosterone and SHBG in various PCOS categories based on the mode of secretion of LH in relation to FSH levels. Acta Endocrinol. Buchar. 17(3), 313\u2013318 (2021).","journal-title":"Acta Endocrinol. Buchar."},{"issue":"6","key":"58064_CR53","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5468\/ogs.2016.59.6.498","volume":"59","author":"CH Park","year":"2016","unstructured":"Park, C. H. & Chun, S. Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome. Obstet. Gynecol. Sci. 59(6), 498\u2013505. https:\/\/doi.org\/10.5468\/ogs.2016.59.6.498 (2016).","journal-title":"Obstet. Gynecol. Sci."},{"issue":"12","key":"58064_CR54","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/en.2016-1613","volume":"157","author":"RC Cardoso","year":"2016","unstructured":"Cardoso, R. C., Burns, A., Moeller, J., Skinner, D. C. & Padmanabhan, V. Developmental programming: Insulin sensitizer prevents the GnRH-stimulated LH hypersecretion in a sheep model of PCOS. Endocrinology 157(12), 4641\u20134653. https:\/\/doi.org\/10.1210\/en.2016-1613 (2016).","journal-title":"Endocrinology"},{"issue":"3","key":"58064_CR55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4183\/aeb.2021.313","volume":"17","author":"NA Malini","year":"2021","unstructured":"Malini, N. A. & Roy, G. K. Influence of insulin on LH, testosterone and SHBG in various PCOS categories based on the mode of secretion of LH in relation to FSH levels. Acta Endocrinol. (Buchar) 17(3), 313\u2013318. https:\/\/doi.org\/10.4183\/aeb.2021.313 (2021).","journal-title":"Acta Endocrinol. (Buchar)"},{"issue":"7","key":"58064_CR56","first-page":"463","volume":"24","author":"S Haider","year":"2014","unstructured":"Haider, S., Mannan, N., Khan, A. & Qureshi, M. A. Influence of anthropometric measurements on abnormal gonadotropin secretion in women with polycystic ovary syndrome. J. Coll. Phys. Surg. Pak. 24(7), 463\u2013466 (2014).","journal-title":"J. Coll. Phys. Surg. Pak."},{"issue":"5","key":"58064_CR57","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.12669\/pjms.35.5.742","volume":"35","author":"A Khan","year":"2019","unstructured":"Khan, A., Karim, N., Ainuddin, J. A. & Fahim, M. F. Polycystic ovarian syndrome: Correlation between clinical hyperandrogenism, anthropometric, metabolic and endocrine parameters. Pak. J. Med. Sci. 35(5), 1227\u20131232. https:\/\/doi.org\/10.12669\/pjms.35.5.742 (2019).","journal-title":"Pak. J. Med. Sci."},{"key":"58064_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","volume":"46","author":"AM Moore","year":"2017","unstructured":"Moore, A. M. & Campbell, R. E. Polycystic ovary syndrome: Understanding the role of the brain. Front. Neuroendocr. 46, 1\u201314 (2017).","journal-title":"Front. Neuroendocr."},{"key":"58064_CR59","first-page":"1","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz, R. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Prim. 2, 1\u201318 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"58064_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido, M. A. & Tena-Sempere, M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol. Metab. 35, 100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001 (2020).","journal-title":"Mol. Metab."},{"key":"58064_CR61","first-page":"1","volume":"149","author":"PM Spritzer","year":"2013","unstructured":"Spritzer, P. M., Lecke, S. B., Satler, F. & Morsch, D. M. Adipose tissue dysfunction, adipokine, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction 149, 1\u20139 (2013).","journal-title":"Reproduction"},{"key":"58064_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2042018820938305","volume":"11","author":"MA Abdalla","year":"2020","unstructured":"Abdalla, M. A., Deshmukh, H., Atkin, S. & Sathyapalan, T. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 11, 1\u201319. https:\/\/doi.org\/10.1177\/2042018820938305 (2020).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"11","key":"58064_CR63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11343","volume":"12","author":"K Shah","year":"2020","unstructured":"Shah, K., Kulkarni, R., Singh, R., Pannu, H. S. & Kamrai, D. Role of bupropion and naltrexone in managing depression with polycystic ovary syndrome: A case report and literature review. Cureus 12(11), e11343. https:\/\/doi.org\/10.7759\/cureus.11343 (2020).","journal-title":"Cureus"},{"issue":"8","key":"58064_CR64","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27689","volume":"14","author":"S Akre","year":"2022","unstructured":"Akre, S., Sharma, K., Chakole, S. & Wanjari, M. B. Recent advances in the management of polycystic ovary syndrome: A review article. Cureus 14(8), e27689. https:\/\/doi.org\/10.7759\/cureus.27689 (2022).","journal-title":"Cureus"},{"issue":"4","key":"58064_CR65","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/biolre\/ioab103","volume":"105","author":"AN Lindo","year":"2021","unstructured":"Lindo, A. N. et al. Localization of kisspeptin, NKB, and NK3R in the hypothalamus of gilts treated with the progestin altrenogest. Biol. Reprod. 105(4), 1056\u20131067. https:\/\/doi.org\/10.1093\/biolre\/ioab103 (2021).","journal-title":"Biol. Reprod."},{"key":"58064_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.958377","author":"Y Uenoyama","year":"2022","unstructured":"Uenoyama, Y., Tsuchida, H., Nagae, M., Inoue, N. & Tsukamura, H. Opioidergic pathways and kisspeptin in the regulation of female reproduction in mammals. Front Neurosci.2022 https:\/\/doi.org\/10.3389\/fnins.2022.958377 (2022).","journal-title":"Front Neurosci.2022"},{"key":"58064_CR67","doi-asserted-by":"publisher","first-page":"1096187","DOI":"10.3389\/fendo.2023.1096187","volume":"14","author":"S Gurule","year":"2023","unstructured":"Gurule, S., Sustaita-Monroe, J., Padmanabhan, V. & Cardoso, R. Developmental programming of the neuroendocrine axis by steroid hormones: Insights from the sheep model of PCOS. Front. Endocrinol. (Lausanne). 14, 1096187. https:\/\/doi.org\/10.3389\/fendo.2023.1096187 (2023).","journal-title":"Front. Endocrinol. (Lausanne)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58064-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:05:27Z","timestamp":1731690327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58064-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["58064"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-58064-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"19 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8229"}}